Literature DB >> 24902859

Socio-economic disadvantage and demographics as factors in stage of colorectal cancer presentation and survival.

Karen L Barclay1, Paul-Jon Goh, Terri J Jackson.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is common, and early diagnosis improves outcome. Overseas studies have suggested that low socio-economic status (SES) is related to advanced cancer stage at presentation and reduced survival. The situation in Australia is unclear. This study examines the effect of demographic and SES on CRC stage at presentation and survival in a single tertiary centre.
METHODS: Patients undergoing surgical resection for CRC (1 January 2005 to 31 December 2010) were identified, and socio-demographic and histopathological information obtained. Four socio-economic indices using 2006 Australian Census data were assigned by residential postcode. Factors contributing to tumour (T) and American Joint Committee on Cancer (AJCC) stage at presentation and survival were assessed.
RESULTS: Five hundred and fifty-seven patients were included. Results did not support a relationship between SES and either advanced stage at presentation or survival. Only one index (economic resources) was related to a more advanced T stage at presentation (P = 0.011); none were related to AJCC stage or survival. No significant relationship was found between an individual's country of birth, language spoken, private insurance or employment status and presenting with a later T or AJCC stage. Age, AJCC and T stage at diagnosis and emergency presentation significantly affected survival on multivariate analysis.
CONCLUSION: SES and most demographic factors did not appear to significantly influence CRC stage at presentation and outcome. A focus on obtaining equivalent access to health care both nationally and internationally could prove beneficial in improving outcomes for CRC.
© 2014 Royal Australasian College of Surgeons.

Entities:  

Keywords:  Australia; colorectal cancer; socio-economic status; staging

Mesh:

Year:  2014        PMID: 24902859     DOI: 10.1111/ans.12709

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  7 in total

1.  Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database.

Authors:  Omar Abdel-Rahman
Journal:  Int J Clin Oncol       Date:  2019-06-25       Impact factor: 3.402

2.  Overexpression of mRNA-decapping enzyme 1a affects survival rate in colorectal carcinoma.

Authors:  Chuanqing Wu; Weizhen Liu; Tuo Ruan; Xiaojie Zhu; Kaixiong Tao; Weikang Zhang
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

3.  Anal cancer survival: a socioeconomic analysis.

Authors:  F Ali; A E Ghareeb; A Jha; H Van der Voet; D Garg; M Jha
Journal:  Ann R Coll Surg Engl       Date:  2021-03       Impact factor: 1.951

4.  Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?

Authors:  Sandar Tin Tin; J Mark Elwood; Ross Lawrenson; Ian Campbell; Vernon Harvey; Sanjeewa Seneviratne
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

5.  Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.

Authors:  Eloïse Berger; Cyrille Delpierre; Fabien Despas; Sarah Bertoli; Emilie Bérard; Oriane Bombarde; Pierre Bories; Audrey Sarry; Guy Laurent; Christian Récher; Sébastien Lamy
Journal:  BMC Cancer       Date:  2019-09-05       Impact factor: 4.430

6.  Spatial Variation of Survival for Colorectal Cancer in Malaysia.

Authors:  Anis Kausar Ghazali; Thomas Keegan; Benjamin M Taylor
Journal:  Int J Environ Res Public Health       Date:  2021-01-25       Impact factor: 3.390

7.  Determinants of emergency presentation in patients with colorectal cancer: a systematic review and meta-analysis.

Authors:  Allan M Golder; Donald C McMillan; Paul G Horgan; Campbell S D Roxburgh
Journal:  Sci Rep       Date:  2022-03-14       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.